Ares Financial Consulting
BIIB icon

Ares Financial Consulting’s Biogen BIIB Stock Holding History

Ares Financial Consulting’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.8K Hold
123
– – 0.02% 343
2026
Q2 		$26.6K Hold
123
– – 0.02% 353
2026
Q1 		$22.6K Buy
123
+98
+392% +$18.1K 0.02% 366
2025
Q4 		$4.4K Buy
+25
New +$4.08K ﹤0.01% 510

Other funds holding BIIB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Ares Financial Consulting's BIIB Position: Q3 2026 in Review

Ares Financial Consulting held its Biogen (BIIB) position steady in Q3 2026 at 123 shares worth $27.8K. The position accounts for 0.02% of the portfolio, ranked #343.

Ares Financial Consulting first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 532 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Ares Financial Consulting held 123 shares of Biogen worth $27.8K as of Q3 2026.
  • Ares Financial Consulting left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.02% of Ares Financial Consulting's portfolio in Q3 2026, its #343 holding.
  • Ares Financial Consulting first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 532 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.